JBIO - Aerovate Therapeutics, Inc.
14.05
0.170 1.210%
Share volume: 299,346
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$13.88
0.17
0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-13-2024 | 08-12-2024 | 11-12-2024 | 03-27-2025 | 04-25-2025 | 11-14-2025 | |
| Cash flow financing | 471.000 K | 24.380 M | 22.000 K | 554.000 K | 0.000 | 0.000 | |
| Other financing cash flows | 704.000 K | 511.000 K | 22.000 K | 247.000 K | 0.000 | -156.000 K | |
| Cash flow | -14.369 M | 21.947 M | 46.000 K | 2.636 M | 10.469 M | 0.000 | |
| Net income | -23.186 M | -24.775 M | -16.237 M | -5.430 M | -2.518 M | -25.175 M | |
| Depreciation | 28.000 K | 28.000 K | 218.000 K | 8.000 K | 4.000 K | 12.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 8.833 M | 18.000 M | 16.067 M | 13.129 M | 12.850 M | -148.708 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 57.000 K | |
| Cash Change | -14.369 M | 21.947 M | 46.000 K | 2.636 M | 10.469 M | -170.836 M |